Total Return chart Regeneron Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 05/09/2026 +04			5-day change	1st Jan Change
827.72 ^USD	-1.87%		+4.22%	+7.24%

09-01	Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says	MT
08-29	Regeneron Pharmaceuticals Inc Initiates Recall of Libtayo (Cemiplimab-Rwlc) Injection, 350 Mg/7 Ml (50 Mg/Ml) For Intravenous Infusion After Dilution, Single-Dose Vial	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.